Brian Still
Family Medicine · Logan, OHNPI 1205857257
Payments from drug & device makers
Across 94 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$395
- Novo Nordisk$196
- Abbott$194
- Neurocrine Biosciences, Inc.$121
- AstraZeneca$87
- Corcept Therapeutics$59
- plus $441 from 16 others
What the payments were for
- Food & beverage$1,494100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $395 |
| Novo Nordisk | 14 | $196 |
| Abbott | 13 | $194 |
| Neurocrine Biosciences, Inc. | 1 | $121 |
| AstraZeneca | 5 | $87 |
| Corcept Therapeutics | 3 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $57 |
| Sunovion Pharmaceuticals Inc. | 5 | $49 |
| Lilly USA, LLC | 3 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Exact Sciences | 2 | $35 |
| Amgen | 2 | $29 |
| Bayer | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Medtronic | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Pfizer | 1 | $14 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$121
How this compares
$1,494 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 143 | $121,143 |
| JanuviaSitagliptin Phosphate | 34 | $41,351 |
| FarxigaDapagliflozin Propanediol | 66 | $39,956 |
| OzempicSemaglutide | 27 | $25,964 |
| RybelsusSemaglutide | 19 | $23,905 |
| XareltoRivaroxaban | 26 | $23,240 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $22,053 |
| JanumetSitagliptin Phos/Metformin Hcl | 13 | $18,352 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 31 | $16,325 |
| MounjaroTirzepatide | 16 | $15,948 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $14,896 |
| LyricaPregabalin | 12 | $11,003 |
| Novolog FlexpenInsulin Aspart | 23 | $9,645 |
| DuleraMometasone/Formoterol | 12 | $7,324 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 64 | $6,012 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Lyrica | $14 | $132,145155 claims |
| Novo NordiskOzempic, Rybelsus | $196 | $49,86946 claims |
| AstraZenecaFarxiga, Symbicort | $87 | $42,24077 claims |
| Johnson & JohnsonXarelto | $15 | $23,24026 claims |
| Boehringer IngelheimCombivent Respimat | $15 | $16,32531 claims |
| Lilly USA, LLCMounjaro | $41 | $15,94816 claims |
| GSKTrelegy Ellipta | $13 | $14,89620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Logan
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.